Cargando…

Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study

OBJECTIVE: To examine the effects of low-to-high doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome (OHSS) in an experimental setting. MATERIALS AND METHODS: A total of 20 female Wistar albino rats, 22 days of age, were randomly div...

Descripción completa

Detalles Bibliográficos
Autores principales: Pala, Şehmus, Atilgan, Remzi, Ozkan¹, Zehra Sema, Kavak, Salih Burçin, Ilhan, Nevin, Akpolat, Nusret, Sapmaz, Ekrem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378285/
https://www.ncbi.nlm.nih.gov/pubmed/25848212
http://dx.doi.org/10.2147/DDDT.S75266
_version_ 1782364042360258560
author Pala, Şehmus
Atilgan, Remzi
Ozkan¹, Zehra Sema
Kavak, Salih Burçin
Ilhan, Nevin
Akpolat, Nusret
Sapmaz, Ekrem
author_facet Pala, Şehmus
Atilgan, Remzi
Ozkan¹, Zehra Sema
Kavak, Salih Burçin
Ilhan, Nevin
Akpolat, Nusret
Sapmaz, Ekrem
author_sort Pala, Şehmus
collection PubMed
description OBJECTIVE: To examine the effects of low-to-high doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome (OHSS) in an experimental setting. MATERIALS AND METHODS: A total of 20 female Wistar albino rats, 22 days of age, were randomly divided into four groups. Follicle-stimulating hormone 10 IU was administered subcutaneously in 15 rats on 4 consecutive days, with OHSS induction on day 5 by 30 IU of human chorionic gonadotropin. Group 1 (n=5) comprised 35-day-old control rats, group 2 (n=5) 35-day-old OHSS rats, group 3 (n=5) 27-day-old OHSS rats receiving 1 mg/kg of oral tamoxifen for 7 days, group 4 (n=5) 27-day-old OHSS rats receiving 3 mg/kg of oral tamoxifen for 7 days. All rats were decapitated on day 35. Serum VEGF, endothelin 1, and ovarian follicular reserve were assessed in all rats. Kruskal–Wallis variance analysis and the Mann–Whitney U-test were used for statistical comparisons. A Bonferroni correction was performed to control the inflation of significance, with a significance level set at a P-value of less than 0.025. RESULTS: Despite higher serum VEGF, endothelin 1, follicular reserve, and angiogenesis and fibrosis of the corpus luteum in the OHSS group compared to controls, these differences were not significant (P>0.025, Mann–Whitney U-test). There was a significant reduction in the ovarian follicular reserve in tamoxifen groups compared to controls (P<0.025, Mann–Whitney U-test), while angiogenesis of the corpus luteum, number of atretic follicles, fibrosis, and serum VEGF were significantly higher in rats receiving tamoxifen (P<0.025, Mann–Whitney U-test). Also, significantly lower follicular reserve and fibrosis were observed among rats in the low-dose tamoxifen group in comparison with rats in the high-dose tamoxifen group (P<0.025, Mann–Whitney U-test). No groups had a significant change in endothelin 1 levels (P>0.025, Mann–Whitney U-test). CONCLUSION: Tamoxifen 1 g and 3 g resulted in a dose-dependent increase in VEGF and endothelin 1 levels, and ovarian follicle reserves were significantly reduced in our experimental model.
format Online
Article
Text
id pubmed-4378285
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43782852015-04-06 Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study Pala, Şehmus Atilgan, Remzi Ozkan¹, Zehra Sema Kavak, Salih Burçin Ilhan, Nevin Akpolat, Nusret Sapmaz, Ekrem Drug Des Devel Ther Original Research OBJECTIVE: To examine the effects of low-to-high doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome (OHSS) in an experimental setting. MATERIALS AND METHODS: A total of 20 female Wistar albino rats, 22 days of age, were randomly divided into four groups. Follicle-stimulating hormone 10 IU was administered subcutaneously in 15 rats on 4 consecutive days, with OHSS induction on day 5 by 30 IU of human chorionic gonadotropin. Group 1 (n=5) comprised 35-day-old control rats, group 2 (n=5) 35-day-old OHSS rats, group 3 (n=5) 27-day-old OHSS rats receiving 1 mg/kg of oral tamoxifen for 7 days, group 4 (n=5) 27-day-old OHSS rats receiving 3 mg/kg of oral tamoxifen for 7 days. All rats were decapitated on day 35. Serum VEGF, endothelin 1, and ovarian follicular reserve were assessed in all rats. Kruskal–Wallis variance analysis and the Mann–Whitney U-test were used for statistical comparisons. A Bonferroni correction was performed to control the inflation of significance, with a significance level set at a P-value of less than 0.025. RESULTS: Despite higher serum VEGF, endothelin 1, follicular reserve, and angiogenesis and fibrosis of the corpus luteum in the OHSS group compared to controls, these differences were not significant (P>0.025, Mann–Whitney U-test). There was a significant reduction in the ovarian follicular reserve in tamoxifen groups compared to controls (P<0.025, Mann–Whitney U-test), while angiogenesis of the corpus luteum, number of atretic follicles, fibrosis, and serum VEGF were significantly higher in rats receiving tamoxifen (P<0.025, Mann–Whitney U-test). Also, significantly lower follicular reserve and fibrosis were observed among rats in the low-dose tamoxifen group in comparison with rats in the high-dose tamoxifen group (P<0.025, Mann–Whitney U-test). No groups had a significant change in endothelin 1 levels (P>0.025, Mann–Whitney U-test). CONCLUSION: Tamoxifen 1 g and 3 g resulted in a dose-dependent increase in VEGF and endothelin 1 levels, and ovarian follicle reserves were significantly reduced in our experimental model. Dove Medical Press 2015-03-24 /pmc/articles/PMC4378285/ /pubmed/25848212 http://dx.doi.org/10.2147/DDDT.S75266 Text en © 2015 Pala et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Pala, Şehmus
Atilgan, Remzi
Ozkan¹, Zehra Sema
Kavak, Salih Burçin
Ilhan, Nevin
Akpolat, Nusret
Sapmaz, Ekrem
Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study
title Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study
title_full Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study
title_fullStr Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study
title_full_unstemmed Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study
title_short Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study
title_sort effect of varying doses of tamoxifen on ovarian histopathology, serum vegf, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378285/
https://www.ncbi.nlm.nih.gov/pubmed/25848212
http://dx.doi.org/10.2147/DDDT.S75266
work_keys_str_mv AT palasehmus effectofvaryingdosesoftamoxifenonovarianhistopathologyserumvegfandendothelin1levelsinovarianhyperstimulationsyndromeanexperimentalstudy
AT atilganremzi effectofvaryingdosesoftamoxifenonovarianhistopathologyserumvegfandendothelin1levelsinovarianhyperstimulationsyndromeanexperimentalstudy
AT ozkan1zehrasema effectofvaryingdosesoftamoxifenonovarianhistopathologyserumvegfandendothelin1levelsinovarianhyperstimulationsyndromeanexperimentalstudy
AT kavaksalihburcin effectofvaryingdosesoftamoxifenonovarianhistopathologyserumvegfandendothelin1levelsinovarianhyperstimulationsyndromeanexperimentalstudy
AT ilhannevin effectofvaryingdosesoftamoxifenonovarianhistopathologyserumvegfandendothelin1levelsinovarianhyperstimulationsyndromeanexperimentalstudy
AT akpolatnusret effectofvaryingdosesoftamoxifenonovarianhistopathologyserumvegfandendothelin1levelsinovarianhyperstimulationsyndromeanexperimentalstudy
AT sapmazekrem effectofvaryingdosesoftamoxifenonovarianhistopathologyserumvegfandendothelin1levelsinovarianhyperstimulationsyndromeanexperimentalstudy